ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
![Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet](https://www.thelancet.com/cms/attachment/9d7cf466-e8a0-47f0-8ec3-08da1c7ce5e9/gr2_lrg.jpg)
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
![2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/94444aed-69b7-4859-b701-d33c352d1b28/joa312652-fig-0004-m.jpg)
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
![Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/0f878952-5093-4326-8522-37e5b401b7c1/gr4.jpg)
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial | JACC: Cardiovascular Interventions
![From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal](https://www.ejinme.com/cms/asset/09fefda2-faea-41dc-87f9-6fe542729b8a/gr1.jpg)
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal
![Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet](https://www.thelancet.com/cms/attachment/69234b20-9c84-42ba-bbc2-8a6e3c87e1fc/gr1_lrg.gif)
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study | PLOS ONE
![Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI](https://ars.els-cdn.com/content/image/1-s2.0-S000287031730337X-gr1.jpg)
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
![Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/12f748d5-c9e9-47fe-9110-c2f0056103d4/e004395fig03.jpeg)
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
![The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/2017-11/CE78021B-FDD9-438F-9EBF-296EF9F7AE8E.png)
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com
![The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2017-11/CE78021B-FDD9-438F-9EBF-296EF9F7AE8E.png?itok=6HjyuOty)